198 related articles for article (PubMed ID: 26079538)
1. AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.
Park J; Schlederer M; Schreiber M; Ice R; Merkel O; Bilban M; Hofbauer S; Kim S; Addison J; Zou J; Ji C; Bunting ST; Wang Z; Shoham M; Huang G; Bago-Horvath Z; Gibson LF; Rojanasakul Y; Remick S; Ivanov A; Pugacheva E; Bunting KD; Moriggl R; Kenner L; Tse W
Oncotarget; 2015 Aug; 6(24):20697-710. PubMed ID: 26079538
[TBL] [Abstract][Full Text] [Related]
2. Recombinant expression and purification of AF1q and its interaction with T-cell Factor 7.
Khan N; Park J; Dean WL; Gray RD; Tse W; Lee D; Sabo TM
Protein Expr Purif; 2020 Jan; 165():105499. PubMed ID: 31541685
[TBL] [Abstract][Full Text] [Related]
3. MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.
Park J; Kim S; Joh J; Remick SC; Miller DM; Yan J; Kanaan Z; Chao JH; Krem MM; Basu SK; Hagiwara S; Kenner L; Moriggl R; Bunting KD; Tse W
Oncotarget; 2016 Jul; 7(28):43960-43973. PubMed ID: 27259262
[TBL] [Abstract][Full Text] [Related]
4. Involvement of AF1q/MLLT11 in the progression of ovarian cancer.
Tiberio P; Lozneanu L; Angeloni V; Cavadini E; Pinciroli P; Callari M; Carcangiu ML; Lorusso D; Raspagliesi F; Pala V; Daidone MG; Appierto V
Oncotarget; 2017 Apr; 8(14):23246-23264. PubMed ID: 28423573
[TBL] [Abstract][Full Text] [Related]
5. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer.
Gruber ES; Oberhuber G; Birner P; Schlederer M; Kenn M; Schreiner W; Jomrich G; Schoppmann SF; Gnant M; Tse W; Kenner L
Cells; 2019 Oct; 8(11):. PubMed ID: 31671695
[TBL] [Abstract][Full Text] [Related]
6. AF1q Expression Associates with CD44 and STAT3 and Impairs Overall Survival in Adenoid Cystic Carcinoma of the Head and Neck.
Kadletz LC; Brkic FF; Jank BJ; Schneider S; Cede J; Seemann R; Gruber ES; Gurnhofer E; Heiduschka G; Kenner L
Pathol Oncol Res; 2020 Apr; 26(2):1287-1292. PubMed ID: 31273546
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis.
Li DQ; Hou YF; Wu J; Chen Y; Lu JS; Di GH; Ou ZL; Shen ZZ; Ding J; Shao ZM
Eur J Cancer; 2006 Dec; 42(18):3274-86. PubMed ID: 16979889
[TBL] [Abstract][Full Text] [Related]
8. Identification of the functional role of AF1Q in the progression of breast cancer.
Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2008 Sep; 111(1):65-78. PubMed ID: 17929166
[TBL] [Abstract][Full Text] [Related]
9. AF1q Mediates Tumor Progression in Colorectal Cancer by Regulating AKT Signaling.
Hu J; Li G; Liu L; Wang Y; Li X; Gong J
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475127
[TBL] [Abstract][Full Text] [Related]
10. Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia.
Li W; Ji M; Lu F; Pang Y; Dong X; Zhang J; Li P; Ye J; Zang S; Ma D; Ji C
Cell Death Dis; 2018 Aug; 9(9):855. PubMed ID: 30154435
[TBL] [Abstract][Full Text] [Related]
11. AF1q/MLLT11 regulates the emergence of human prothymocytes through cooperative interaction with the Notch signaling pathway.
Parcelier A; Maharzi N; Delord M; Robledo-Sarmiento M; Nelson E; Belakhdar-Mekid H; Pla M; Kuranda K; Parietti V; Goodhardt M; Legrand N; Bernstein ID; Gluckman JC; Sigaux F; Canque B
Blood; 2011 Aug; 118(7):1784-96. PubMed ID: 21715312
[TBL] [Abstract][Full Text] [Related]
12. Activation of Wnt signaling pathway by AF1q enriches stem-like population and enhance mammosphere formation of breast cells.
Tse CO; Kim S; Park J
Biochem Biophys Res Commun; 2017 Mar; 484(4):884-889. PubMed ID: 28188793
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer.
Chen WY; Liu SY; Chang YS; Yin JJ; Yeh HL; Mouhieddine TH; Hadadeh O; Abou-Kheir W; Liu YN
Oncotarget; 2015 Jan; 6(1):441-57. PubMed ID: 25436980
[TBL] [Abstract][Full Text] [Related]
14. AF1q Contributes to Adriamycin-Induced Podocyte Injury by Activating Wnt/β-Catenin Signaling.
Zhang H; Ren R; Du J; Sun T; Wang P; Kang P
Kidney Blood Press Res; 2017; 42(5):794-803. PubMed ID: 29069662
[TBL] [Abstract][Full Text] [Related]
15. A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells.
Tse W; Zhu W; Chen HS; Cohen A
Blood; 1995 Feb; 85(3):650-6. PubMed ID: 7833468
[TBL] [Abstract][Full Text] [Related]
16. RE1 silencing transcription factor (REST) negatively regulates ALL1-fused from chromosome 1q (AF1q) gene transcription.
Hu Y; Sun Q; Zhang C; Sha Q; Sun X
BMC Mol Biol; 2015 Sep; 16():15. PubMed ID: 26341630
[TBL] [Abstract][Full Text] [Related]
17. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of ACE2/Ang-(1-7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry.
Yu C; Tang W; Wang Y; Shen Q; Wang B; Cai C; Meng X; Zou F
Cancer Lett; 2016 Jul; 376(2):268-77. PubMed ID: 27063099
[TBL] [Abstract][Full Text] [Related]
19. WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
Jiang W; Crossman DK; Mitchell EH; Sohn P; Crowley MR; Serra R
PLoS One; 2013; 8(3):e58329. PubMed ID: 23484019
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia.
Tse W; Meshinchi S; Alonzo TA; Stirewalt DL; Gerbing RB; Woods WG; Appelbaum FR; Radich JP
Blood; 2004 Nov; 104(10):3058-63. PubMed ID: 15217837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]